Published in Pharma Investments, Ventures and Law Weekly, November 13th, 2005
"We believe that this successful offering will provide us increased financial flexibility to continue our strategy to establish ATS Medical as the leading provider of technologies used by the cardiac surgeon," said Michael Dale, chairman, president and CEO.
"Over the past 18 months, we have successfully expanded our franchise to include five innovative product opportunities in addition to our core product, the ATS Open Pivot mechanical heart valve. This strategy leverages our cost structure while expanding our revenue base. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly